Spero
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
675 Massachusetts Ave Ste 14, Cambridge,...Phone Number
(857) 242-1600Website
www.sperotx.comRevenue
$43 MillionIndustry
About Spero
Spero Therapeutics (Nasdaq: SPRO) is a Cambridge, MA-based biotech company. In mid-2026, it executed a major strategic pivot from infectious diseases to immunology and inflammation. This shift is anchored by SP001, a licensed Phase 2-ready anti-CD40L antibody targeting IgG4-related disease. Spero also secured FDA approval for Utebzi, the first oral carbapenem for urinary tract infections. Spero monetized these drug royalties to fund its new pipeline.Explore more
Spero Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Spero Tech Stack
A closer look at the technologies used by Spero
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Spero
Sign Up For FreeTo access detailed company insights
Spero Therapeutics (Nasdaq: SPRO) is a Cambridge, MA-based biotech company. In mid-2026, it executed a major strategic pivot from infectious diseases to immunology and inflammation. This shift is anchored by SP001, a licensed Phase 2-ready anti-CD40L antibody targeting IgG4-related disease. Spero also secured FDA approval for Utebzi, the first oral... Read More
